Mac sore throat dual action blackcurrant flavour lozenges are a type of over-the-counter medication that is used to relieve sore throats and associated pain. They contain two active ingredients: Hexylresorcinol and Amylmetacresol. Hexylresorcinol is an antiseptic that helps to combat the bacteria that cause sore throats, while Amylmetacresol acts as a local anaesthetic to bring soothing relief from pain and discomfort. Mac dual action blackcurrant lozenges are recommended for adults and children
MAC sore throat lozenges blackcurrant flavour 16
$1.69
Availability: in stock
1 view this product.
Estimate delivery times: 12-26 days (International).
Return within 30 days of purchase. Taxes are non-refundable.
Guarantee safe & Secure checkout
Side Effects
Please consult the product leaflet for side effects information.
FAQ
How do I take these lozenges?
Mac sore throat dual action blackcurrant flavour lozenges are recommended for adults and children over 6 years of age. The usual dose is to dissolve one lozenge slowly in the mouth every 3 hours or as required. Do not take more than 12 lozenges in 24 hours.
Do not give these lozenges to children under 6 years old. Do not take these lozenges if you are allergic to Hexylresorcinol or any of the other ingredients.
If your symptoms worsen or do not improve after 7 days, talk to your doctor.
How will Mac dual action blackcurrant flavour lozenges help?
Mac sore throat dual action blackcurrant flavour lozenges work in two ways:
Antiseptic action: Hexylresorcinol is an antiseptic that helps to kill the bacteria that cause sore throats
Local anaesthetic action: Amylmetacresol acts as a local anaesthetic to numb the pain and discomfort of a sore throat.
When you dissolve a lozenge in your mouth, the active ingredients are released and coat the lining of your throat. This helps to kill the bacteria, numb the pain, and soothe the irritation.
The lozenges also help to increase saliva production, which can help to loosen mucus and make it easier to cough up.
Reviews
There are no reviews yet.